stockrowPfizer Inc.
PFE Healthcare Drug Manufacturers General
Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.
- Revenue
- −0.43%
- EPS
- −7.98%
- Free cash flow
- +20.0%
- Total debt
- +1.55%
Quarter to September 2026, against a year earlier
Follow PFE
Alert me
Pfizer Inc. (PFE) Book value per share
Pfizer Inc.'s book value per share at the end of fiscal 2025 was 15.3×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 15.7×. Over the past ten years it has ranged from 9.8× (fiscal 2016) to 17.1× (fiscal 2022); the current reading is higher than 73% of that period. Pfizer Inc. ranks 10th of 21 Drug Manufacturers General companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 15.3× | (2.27%) |
| FY2024 | 15.6× | (1.25%) |
| FY2023 | 15.8× | (7.49%) |
| FY2022 | 17.1× | 23.67% |
| FY2021 | 13.8× | 21.04% |
| FY2020 | 11.4× | 0.29% |
| FY2019 | 11.4× | 4.93% |
| FY2018 | 10.9× | (9.54%) |
| FY2017 | 12.0× | 22.13% |
| FY2016 | 9.8× | (6.62%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 15.7× | 4.44% |
| Jun 2026 | 15.0× | (5.57%) |
| Mar 2026 | 15.9× | 4.04% |
| Dec 2025 | 15.3× | (6.76%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| SNY Sanofi compare | 35.1× |
| AZN AstraZeneca PLC compare | 33.4× |
| AMGN Amgen Inc. compare | 26.5× |
| NVS Novartis AG compare | 19.8× |
| PFE Pfizer Inc. | 15.7× |
| GSK GSK PLC Sponsored ADR compare | 12.3× |
| BMY Bristol Myers Squibb Company compare | 11.5× |
| GILD Gilead Sciences, Inc. compare | 10.4× |
| NVO Novo Nordisk A/S compare | 7.8× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on PFE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement